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Cytisine versus Nicotine for Smoking Cessation
To the Editor: Walker et al. (Dec. 18 issue)1 de-
scribe the use of cytisine, as compared with nico-
tine, for smoking cessation. Although cytisine is 
perceived as a novelty in the West, it has been 
used in daily medical practice in Poland for more 
than 50 years.2 In 1976, the first English-lan-
guage study on the use of cytisine in Poland was 
published, based on the observations of 1968 pa-
tients.3 Cytisine is currently undergoing a renais-
sance in Poland. Two Polish studies — a cohort 
study conducted in 2003 through 20054 and a 
randomized, controlled trial conducted in 2006 
through 20105 — showed the safety and effec-
tiveness of the drug. In 2012, a Polish generic 
drug company broke the monopoly by introduc-
ing a new cytisine product, Desmoxan. Cytisine 
is very inexpensive in Poland, costing under $20 
for full treatment. Its consumption has grown by 
factor of 10 since 2000 (Fig. 1). In 2013 alone, 
after cytisine became available over the counter 
and was heavily advertised, sales of the drug dou-
bled. The use of cytisine is widespread, and it is 
considered to be safe by medical professionals 
and consumers. It seems that the use of cytisine 
is a major factor behind the decline in smoking 
in Poland — in the past 2 years, 500,000 smokers 
have quit.6 It is certainly desirable for this suc-
cess to be replicated elsewhere.
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Figure 1. Total Units of Cytisine Purchased as Smoking-
Cessation Therapy in Poland, 2000–2013.
Each unit (or package) of cytisine is one full treatment 
for smoking cessation. The solid black line indicates 
the trend in sales between 2000 and 2013.
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